Jump to content

Agenda for the July 2020 PBAC meeting


Nev Black

Recommended Posts

Agenda for the July 2020 PBAC meeting

29 April 2020

The agenda for the July 2020 PBAC meeting is now available. Your comments are welcome whether you are a patient, carer, member of the public, health professional or member of a consumer interest group. The company applying for subsidy under the Pharmaceutical Benefits Scheme has already provided the PBAC with detailed clinical and economic data in support of the application. You are welcome to provide comments, for consideration by the PBAC, from a personal or group perspective on the impact of the condition addressed in the application. The Consumer Comments Submission form and further information can be found on the PBS website.

Kind regards,


PBS Publications team
Pharmaceutical Benefits Scheme
Department of Health
www.pbs.gov.au

New listing

(Major Submission)

DAROLUTAMIDE

Tablet 300 mg

Nubeqa®

Bayer Australia Pty Ltd

Prostate cancer

To request an Authority Required listing for the treatment of non-metastatic castration-resistant prostate cancer. 

 
Link to comment
Share on other sites

×
×
  • Create New...